Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited) - USD ($)
|
Preferred Stock [Member]
Series A Preferred Stock [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Stock To Be Issued [Member] |
Subscription Receivable [Member] |
Retained Earnings [Member] |
Total |
Balance at Mar. 31, 2022 |
$ 500
|
$ 67,500
|
$ 96,701,607
|
$ 20,132,650
|
|
$ (150,036,023)
|
$ (33,133,765)
|
Balance, shares at Mar. 31, 2022 |
5,000,000
|
674,644,124
|
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders |
|
$ 6,112
|
19,311,486
|
(19,317,598)
|
|
|
|
Common stock issued for legal settlement to NSH shareholders, shares |
|
61,154,136
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
$ 454
|
839,546
|
|
|
|
840,000
|
Conversion of Series E Preferred Shares to common stock, shares |
|
4,537,240
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(102,227)
|
(102,227)
|
Net income (loss) |
|
|
|
|
|
(2,200,176)
|
(2,200,176)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
(278,500)
|
(278,500)
|
Contingent beneficial conversion feature related to the Series E Preferred Shares, fully amortized |
|
|
99,000
|
|
|
(99,000)
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
(42,500)
|
(42,500)
|
Common stock issued in business agreement, to be paid from revenue earned |
|
$ 25
|
56,225
|
|
(56,250)
|
|
|
Common stock issued in business agreement, to be paid from revenue earned, shares |
|
250,000
|
|
|
|
|
|
Common stock vested to consultants |
|
$ 6
|
24,369
|
|
|
|
24,375
|
Balance at Jun. 30, 2022 |
$ 500
|
$ 74,097
|
117,032,233
|
815,052
|
(56,250)
|
(152,758,426)
|
(34,892,793)
|
Balance, shares at Jun. 30, 2022 |
5,000,000
|
740,585,500
|
|
|
|
|
|
Balance at Mar. 31, 2022 |
$ 500
|
$ 67,500
|
96,701,607
|
20,132,650
|
|
(150,036,023)
|
(33,133,765)
|
Balance, shares at Mar. 31, 2022 |
5,000,000
|
674,644,124
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(11,552,820)
|
Balance at Dec. 31, 2022 |
$ 500
|
$ 76,894
|
119,464,471
|
662,767
|
(56,250)
|
(163,037,985)
|
(42,889,603)
|
Balance, shares at Dec. 31, 2022 |
5,000,000
|
768,561,129
|
|
|
|
|
|
Balance at Jun. 30, 2022 |
$ 500
|
$ 74,097
|
117,032,233
|
815,052
|
(56,250)
|
(152,758,426)
|
(34,892,793)
|
Balance, shares at Jun. 30, 2022 |
5,000,000
|
740,585,500
|
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders |
|
$ 40
|
127,646
|
(127,686)
|
|
|
|
Common stock issued for legal settlement to NSH shareholders, shares |
|
404,067
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
$ 992
|
827,008
|
|
|
(108,000)
|
720,000
|
Conversion of Series E Preferred Shares to common stock, shares |
|
9,920,887
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(55,427)
|
(55,427)
|
Net income (loss) |
|
|
|
|
|
(24,528,345)
|
(24,528,345)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
(278,500)
|
(278,500)
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
(42,500)
|
(42,500)
|
Common stock vested to consultants |
|
6
|
24,369
|
|
|
|
24,375
|
Increase of 10% in Series E Preferred Shares to one holder based on certain rights |
|
|
|
|
|
(156,000)
|
(156,000)
|
Common stock issued in business agreement |
|
$ 25
|
25,975
|
|
|
|
26,000
|
Common stock issued in business agreement, shares |
|
250,000
|
|
|
|
|
|
Common stock issued from shares payable |
|
$ 10
|
24,590
|
(24,600)
|
|
|
|
Common stock issued from shares payable, shares |
|
100,000
|
|
|
|
|
|
Common stock vested to consultants, shares |
|
62,500
|
|
|
|
|
|
Balance at Sep. 30, 2022 |
$ 500
|
$ 75,170
|
118,061,820
|
662,767
|
(56,250)
|
(177,927,198)
|
(59,183,191)
|
Balance, shares at Sep. 30, 2022 |
5,000,000
|
751,322,954
|
|
|
|
|
|
Issuance of common shares under financing agreement |
|
$ 1,718
|
1,378,282
|
|
|
|
1,380,000
|
Issuance of common shares under financing agreement, shares |
|
17,175,675
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(60,107)
|
(60,107)
|
Net income (loss) |
|
|
|
|
|
15,175,701
|
15,175,701
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
(198,333)
|
(198,333)
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
(28,048)
|
(28,048)
|
Common stock vested to consultants |
|
$ 6
|
24,369
|
|
|
|
24,375
|
Common stock vested to consultants, shares |
|
62,500
|
|
|
|
|
|
Balance at Dec. 31, 2022 |
$ 500
|
$ 76,894
|
119,464,471
|
662,767
|
(56,250)
|
(163,037,985)
|
(42,889,603)
|
Balance, shares at Dec. 31, 2022 |
5,000,000
|
768,561,129
|
|
|
|
|
|
Balance at Mar. 31, 2023 |
$ 500
|
$ 80,377
|
121,156,733
|
662,767
|
(56,250)
|
(167,533,292)
|
(45,689,165)
|
Balance, shares at Mar. 31, 2023 |
5,000,000
|
803,123,748
|
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders |
|
$ 86
|
272,657
|
(272,743)
|
|
|
|
Common stock issued for legal settlement to NSH shareholders, shares |
|
863,110
|
|
|
|
|
|
Issuance of common shares under financing agreement |
|
$ 4,019
|
1,294,493
|
|
|
|
1,298,512
|
Issuance of common shares under financing agreement, shares |
|
40,187,311
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
$ 2,399
|
825,601
|
|
|
(350,825)
|
477,175
|
Conversion of Series E Preferred Shares to common stock, shares |
|
23,989,570
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(54,000)
|
(54,000)
|
Common stock issued to consultants |
|
$ 10
|
4,690
|
|
|
|
4,700
|
Common stock issued to consultants, shares |
|
100,000
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
(2,298,431)
|
(2,298,431)
|
Balance at Jun. 30, 2023 |
$ 500
|
$ 86,891
|
123,554,174
|
390,024
|
(56,250)
|
(170,236,548)
|
(46,261,209)
|
Balance, shares at Jun. 30, 2023 |
5,000,000
|
868,263,739
|
|
|
|
|
|
Balance at Mar. 31, 2023 |
$ 500
|
$ 80,377
|
121,156,733
|
662,767
|
(56,250)
|
(167,533,292)
|
(45,689,165)
|
Balance, shares at Mar. 31, 2023 |
5,000,000
|
803,123,748
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(10,347,034)
|
Balance at Dec. 31, 2023 |
$ 500
|
$ 99,560
|
125,327,383
|
390,024
|
(56,250)
|
(178,425,983)
|
(52,664,766)
|
Balance, shares at Dec. 31, 2023 |
5,000,000
|
994,965,427
|
|
|
|
|
|
Balance at Jun. 30, 2023 |
$ 500
|
$ 86,891
|
123,554,174
|
390,024
|
(56,250)
|
(170,236,548)
|
(46,261,209)
|
Balance, shares at Jun. 30, 2023 |
5,000,000
|
868,263,739
|
|
|
|
|
|
Issuance of common shares under financing agreement |
|
$ 3,181
|
563,089
|
|
(109,911)
|
|
456,359
|
Issuance of common shares under financing agreement, shares |
|
31,808,246
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(59,616)
|
(59,616)
|
Net income (loss) |
|
|
|
|
|
(2,646,539)
|
(2,646,539)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
(9,300)
|
(9,300)
|
Balance at Sep. 30, 2023 |
$ 500
|
$ 90,072
|
124,117,263
|
390,024
|
(166,161)
|
(172,952,003)
|
(48,520,305)
|
Balance, shares at Sep. 30, 2023 |
5,000,000
|
900,071,985
|
|
|
|
|
|
Issuance of common shares under financing agreement |
|
$ 4,483
|
454,025
|
|
109,911
|
|
568,419
|
Issuance of common shares under financing agreement, shares |
|
44,843,442
|
|
|
|
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
(59,616)
|
(59,616)
|
Common stock issued to consultants |
|
$ 4,000
|
596,000
|
|
|
|
600,000
|
Common stock issued to consultants, shares |
|
40,000,000
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
(5,402,064)
|
(5,402,064)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
(9,300)
|
(9,300)
|
Shares issued upon exchange of Partitioned Note |
|
$ 1,000
|
159,000
|
|
|
|
160,000
|
Shares issued upon exchange of Partitioned Note, shares |
|
10,000,000
|
|
|
|
|
|
Common stock issued to employee |
|
$ 5
|
1,095
|
|
|
|
1,100
|
Common stock issued to employee, shares |
|
50,000
|
|
|
|
|
|
Accretion on Series G Preferred shares |
|
|
|
|
|
(3,000)
|
(3,000)
|
Balance at Dec. 31, 2023 |
$ 500
|
$ 99,560
|
$ 125,327,383
|
$ 390,024
|
$ (56,250)
|
$ (178,425,983)
|
$ (52,664,766)
|
Balance, shares at Dec. 31, 2023 |
5,000,000
|
994,965,427
|
|
|
|
|
|